Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that it will present three posters, including two late breaker abstracts, at the 50th Annual Meeting of the …
Shares of Achillion Pharmaceuticals (NASDAQ: ACHN) jumped almost 20% in trading on February 9th after the company announced positive interim data results for its hepatitis …
In a research report issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price target, as …
Cowen’s healthcare analyst Phil Nadeau is weighing in with a few insights on Achillion Pharmaceuticals (NASDAQ:ACHN), following new trial results which demonstrated that a combination of the …
In a research report issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price target, …
In a research report released Monday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price …
In a research report issued today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price …
